Minimal Residual Disease (MRD)

MRD Rapid 500 Panel | NGS Minimal Residual Disease Monitoring | IGB

Minimal Residual Disease (MRD)

Overview: 

IGB offers the Twist Bioscience MRD Rapid 500 Panel is a scalable target enrichment solution for monitoring minimal residual disease that leverages Twist’s siliconbased DNA synthesis platform to design and manufacture capture panels for personalized medicine. Twist’s proprietary design algorithms and a streamlined manufacturing pipeline enable design automation, synthesis, and rapid turnaround time of as few as 6 business days from the time of order. Cast a broader net to fully characterize adjuvant response at a genomic level with MRD panels ranging from 50 to 500 probes per panel and are compatible with Twist’s existing NGS library preparation and hybrid capture workflow.

Panel Performance:

Our Resources

MRD Brochure

Product Sheet

Let’s Connect with Expert

From time to time, we may contact you about our products, services, and other content that may be of interest to you. If you would like to receive such communications, please provide your consent below:

+91 8971097244
contactus@igbiosystems.com